Evotec Investor
Evotec is a drug discovery alliance company providing drug discovery solutions to pharmaceutical and biotechnology companies.
.png)
Acquisitions Number:
Made Acquisitions
Founded Date:
1993-01-01
Last Funding Type:
Post-IPO Debt
Headquarters:
Hamburg, Hamburg, Germany
Investors Number:
10.0
Technology:
Biopharma, Biotechnology, Pharmaceutical
Employee Number:
1001-5000
Industry:
End-to-End Drug Development
Estimated Revenue:
$100M to $500M
Last Funding Date:
2023-02-10
Number Of Exists:
2
Funding Status:
IPO
Investor Type:
Not Classified
Total Funding:
733436691.0